ASH 2020: Dr. William Wierda on minimal residual disease (MRD)-guided discontinuation of ibrutinib + venetoclax in chronic lymphocytic leukemia (CLL) ASH 2020: Dr. William Wierda on minimal residual disease (MRD)-guided discontinuation of ibrutinib + venetoclax in chronic lymphocytic leukemia (CLL)... January 29, 20212020 Conferences, MRD & Disease MonitoringBy Brad Hedrick
CAR-T: Targets and Limitations All our MRD educational efforts are directed at the non-medical reader, but they also endeavor to be a true reflection... December 7, 2020CAR-T, The BasicsBy Brad Hedrick
CLL Advocates Network (CLLAN) September 30, 2020 Webinar CLL Society worked with CLL Advocates Network (CLLAN) to produce a webinar on how patient advocacy and professional organizations can... November 1, 2020Archived Education, MRD & Disease MonitoringBy Brad Hedrick
ASH 2019: Dr. Siddiqi Discusses a Clinical Trial of Lisocel®, a CAR-T Therapy for CLL ASH 2019: Dr. Siddiqi Discusses a Clinical Trial of Lisocel®, a CAR-T Therapy for CLL ... October 30, 20202019 Conferences, MRD & Disease MonitoringBy Brad Hedrick
ASH 2019: Dr. Sameer Parikh on Monoclonal B-cell Lymphocytosis, a Precursor to Chronic Lymphocytic Leukemia (CLL) ASH 2019: Dr. Sameer Parikh on Monoclonal B-cell Lymphocytosis, a Precursor to Chronic Lymphocytic Leukemia (CLL) ... October 16, 20202019 Conferences, MRD & Disease MonitoringBy Brad Hedrick
Access to MRD Testing We asked members of the MRD Testing Collaborative what they think the biggest barriers are to MRD testing. Here's what... September 24, 2020The BasicsBy Brad Hedrick
The Importance of MRD Testing We asked members of the MRD Testing Collaborative why MRD testing is important. Here's what they had to say... September 24, 2020The BasicsBy Brad Hedrick
Minimal Residual Disease Testing Dr. Koffman breaks down the key takeaways from a recent medical article that describes the MRD landscape.... September 24, 2020The BasicsBy Brad Hedrick
iwCLL 2019: Dr. Andy Rawstron on minimal residual disease (MRD) testing for chronic lymphocytic leukemia (CLL) In this 2019 iwCLL interview with Dr. Andy Rawstrom, we learn that he is a clinical scientist who helps with... September 24, 20202019 Conferences, MRD & Disease MonitoringBy Brad Hedrick
Minimal Residual Disease Assessment in CLL: Ready for Use in Clinical Routine? All our MRD educational efforts are directed at the non-medical reader, but they also endeavor to be a true reflection... September 17, 2020The BasicsBy Brad Hedrick
